Latest Articles about FOLD

After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP

NASDAQ.com News — Tue, 12 Mar 2013 22:00:05 Z

The following companies are expected to report earnings after hours on 03/12/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Kennedy-Wilson Holdings Inc. (

Glaxo's Influenza Vaccine Approved - Analyst Blog

Zacks Equity Research — Tue, 25 Dec 2012 01:00:01 Z

GlaxoSmithKline ( GSK ) recently announced that it has received US Food and Drug Administration (FDA) approval for its influenza vaccine, Fluarix Quadrivalent for the prevention of

Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog

Zacks Equity Research — Fri, 21 Dec 2012 22:14:01 Z

GlaxoSmithKline ( GSK ) and partner Amicus Therapeutics ( FOLD ) recently presented disappointing top-line six-month primary treatment period data from the first phase III global

Pre-Market Most Active for Dec 20, 2012 : NOK, MDRX, QQQ, BAC, VVUS, ARRS, SD, NJ, PHG, TOT, FOLD, ILMN

NASDAQ.com News — Thu, 20 Dec 2012 18:39:55 Z

The NASDAQ 100 Pre-Market Indicator is up 1.47 to 2,692.46. The total Pre-Market volume is currently 7,742,642 shares traded. The following are the most active stocks for the pre-market

Glaxo's Anthrax Drug Gets FDA Nod - Analyst Blog

Zacks Equity Research — Wed, 19 Dec 2012 03:20:01 Z

GlaxoSmithKline ( GSK ) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug Administration (FDA) approval. Raxibacumab was approved for

Glaxo Invests in Nigeria - Analyst Blog

Zacks Equity Research — Wed, 28 Nov 2012 18:10:01 Z

GlaxoSmithKline ( GSK ) recently announced that it has reached an agreement with GlaxoSmithKline Consumer Nigeria plc regarding its proposal to increase its holding in the latter from 46.4%

Glaxo to Expand in India - Analyst Blog

Zacks Equity Research — Wed, 28 Nov 2012 00:45:01 Z

GlaxoSmithKline ( GSK ) recently announced its decision to increase its holding in its consumer healthcare subsidiary in India from 43.2% to up to 75%. Glaxo plans to increase its stake

Glaxo's Promacta Label Expanded - Analyst Blog

Zacks Equity Research — Tue, 20 Nov 2012 21:20:01 Z

GlaxoSmithKline ( GSK ) recently announced that the US Food and Drug Administration (FDA) has approved an additional indication for Promacta (eltrombopag), also known as Revolade in the EU

Glaxo Misses on Both Counts - Analyst Blog

Zacks Equity Research — Thu, 01 Nov 2012 21:52:01 Z

GlaxoSmithKline ( GSK ) reported third quarter 2012 earnings of 71 cents per American Depository Share (ADS), well below the Zacks Consensus Estimate of 89 cents. Earnings fell 21.1% from

Encouraging Data on Glaxo's Drug - Analyst Blog

Zacks Equity Research — Tue, 09 Oct 2012 01:46:01 Z

GlaxoSmithKline ( GSK ) recently presented positive data on its oncology drug, Votrient (pazopanib) from a pivotal phase III study. The phase III study COMPARZ (COMParing the efficacy, sAfety

Glaxo Aims to Expand Synflorix Label - Analyst Blog

Zacks Equity Research — Wed, 19 Sep 2012 19:34:52 Z

GlaxoSmithKline plc ( GSK ) recently announced that it is seeking to expand the label of Synflorix in EU and has submitted a variation to the marketing authorization application (MAA) for the

Glaxo Increases Stake in RGDX - Analyst Blog

Zacks Equity Research — Wed, 19 Sep 2012 01:35:01 Z

GlaxoSmithKline ( GSK ) recently announced it has hiked its stake in Response Genetics Inc. ( RGDX ), a company focused on the development and sale of molecular diagnostic testing

Glaxo to Increase Stake in Amicus - Analyst Blog

Zacks Equity Research — Fri, 20 Jul 2012 02:08:10 Z

Glaxo Group Limited, an affiliate of GlaxoSmithKline ( GSK ), and Amicus Therapeutics ( FOLD ) recently announced the expansion of their existing agreement related to the development and

Zacks #1 Rank Additions for Friday - Tale of the Tape

Zacks Equity Research — Fri, 11 May 2012 17:09:30 Z

Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: 51job, Inc. ( JOBS ) ACCO Brands Corp. ( ACCO )

Zacks #1 Rank Additions for Wednesday - Tale of the Tape

Zacks Equity Research — Wed, 09 May 2012 17:14:01 Z

Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: Amicus Therapeutics, Inc. ( FOLD ) Ann Inc. ( ANN